Considering that the expression level of PD‐L1 may be a bottleneck for the application of Nb‐CAR‐γδT in the treatment of solid tumors, we analyzed the expression pattern of PD‐L1 and HLA‐G in tumor lesions of NSCLC and TNBC patients. This evidence concerns the gene HLA-G and non-small cell lung carcinoma.